Search results for "coronary disease."

showing 10 items of 202 documents

Small, dense low-density-lipoproteins and the metabolic syndrome.

2006

Small, dense low-density-lipoproteins (LDL) are associated with increased risk for cardiovascular diseases and diabetes mellitus and a reduction in LDL size has been reported in patients with coronary and non-coronary forms of atherosclerosis. LDL size has been accepted as an important predictor of cardiovascular events and progression of coronary artery disease as well as an emerging cardiovascular risk factor by the National Cholesterol Education Program Adult Treatment Panel III. Small, dense LDL, with elevated triglyceride levels and low HDL-cholesterol concentrations, constitute the 'atherogenic lipoprotein phenotype (ALP)', a form of atherogenic dyslipidemia that is a feature of type …

medicine.medical_specialtyEndocrinology Diabetes and MetabolismMyocardial InfarctionCoronary DiseaseType 2 diabetesmetabolic syndromeCoronary artery diseasechemistry.chemical_compoundEndocrinologyatherosclerosipreventionRisk FactorsInternal medicineDiabetes mellitusInternal MedicinemedicineHumansParticle SizeRisk factorNational Cholesterol Education ProgramTriglycerideVascular diseasebusiness.industrydense LDLsmallAtherosclerosismedicine.diseaseLipoproteins LDLEndocrinologyDiabetes Mellitus Type 2chemistrydiabeteCardiologylipids (amino acids peptides and proteins)Metabolic syndromebusiness
researchProduct

Calculating confidence intervals for impact numbers

2006

Abstract Background Standard effect measures such as risk difference and attributable risk are frequently used in epidemiological studies and public health research to describe the effect of exposures. Recently, so-called impact numbers have been proposed, which express the population impact of exposures in form of specific person or case numbers. To describe estimation uncertainty, it is necessary to calculate confidence intervals for these new effect measures. In this paper, we present methods to calculate confidence intervals for the new impact numbers in the situation of cohort studies. Methods Beside the exposure impact number (EIN), which is equivalent to the well-known number needed …

medicine.medical_specialtyEpidemiologyCoronary DiseaseHealth InformaticsRisk AssessmentCohort StudiesJapanRisk FactorsEpidemiologyStatisticsConfidence IntervalsmedicineHumanslcsh:R5-920business.industrySmokingUncertaintyAbsolute risk reductionUnited KingdomConfidence intervalStrokeSample size determinationSample SizeAttributable riskNumber needed to treatlcsh:Medicine (General)Risk assessmentbusinessResearch ArticleCohort studyBMC Medical Research Methodology
researchProduct

Cardiometabolic non-response to aerobic exercise: Identifying subclinical ischaemic coronary disease

2019

Sin financiación 5.864 JCR (2019) Q1, 18/138 Cardiac & Cardiovascular Systems 1.459 SJR (2019) Q1, 58/362 Cardiology and Cardiovascular Medicine; Q2, 36/104 Epidemiology No data IDR 2019 UEM

medicine.medical_specialtyEpidemiologyEnfermedad cardiovascularCardiologyMEDLINECardiometabolic responseCoronary Artery DiseaseCoronary diseaseCoronary artery diseaseInternal medicineDiabetes mellitusmedicineHumansAerobic exerciseExerciseCardiometabolic response aerobic exercise coronary disease.Subclinical infectionMetabolismobusiness.industrymedicine.diseaseaerobic exerciseDiabetes Mellitus Type 2coronary disease.Cardiovascular DiseasesCardiologyCardiopatía coronariaCardiology and Cardiovascular MedicinebusinessEuropean Journal of Preventive Cardiology
researchProduct

Myocardial Protection by Retrograde Cardioplegic Perfusion in the Presence of Acute Coronary Artery Obstruction: An Experimental Study

1992

To investigate retrograde delivery of cardioplegic solutions as a means of enhancing myocardial protection in the presence of coronary artery occlusion, a two-part experimental model was devised. In part 1 (in vitro) the possibility of retroperfusing the entire myocardium during acute occlusion of the left anterior descending artery (LAD) was assessed. In part 2 (in vivo) acute LAD occlusion was performed in dogs, and during 2 hours of aortic cross-clamping crystalline cardioplegic solution was infused at 20-minute intervals. In group I the infusion was antegrade, via the aortic root, and in group II it was retrograde, via the coronary sinus. Thereafter the LAD snare was released and the do…

medicine.medical_specialtyGroup iiContrast MediaBlood PressureCoronary DiseaseCoronary AngiographyPotassium ChlorideDogsBody WaterHypothermia InducedInternal medicineOcclusionmedicineCarnivoraAnimalscardiovascular diseasesCardioplegic SolutionsAortaCoronary sinusCardioprotectionCardiopulmonary Bypassbiologybusiness.industryMyocardiumFissipediaHeartbiology.organism_classificationCoronary VesselsPerfusionmedicine.anatomical_structureAnesthesiaHeart Arrest Inducedcardiovascular systemCardiologyCardiology and Cardiovascular MedicinebusinessPerfusionArteryScandinavian Journal of Thoracic and Cardiovascular Surgery
researchProduct

Quantification of myocardial blood flow and blood flow reserve in the presence of arterial dispersion: A simulation study

2002

Myocardial blood flow (MBF) can be quantified using dynamic T1-weighted MRI of diffusible tracers and a mathematical model of underlying vasculature. Quantification of MBF by means of T1- weighted MRI requires knowledge of the arterial input function (AIF). The AIF can be estimated from the left ventricular (LV) cavity. However, dispersion may occur between the LV and the tissue of interest because of the laminar blood flow profiles, branching of venules, and because of stenosis. To evaluate the influence of dispersion on the results of MBF quantification, a simulation study was performed. The dispersion was described as a convolution of the AIF with an exponential residue function. Synthet…

medicine.medical_specialtyHemodynamicsCoronary DiseaseVentricular Function LeftCoronary CirculationInternal medicinemedicineHumansComputer SimulationRadiology Nuclear Medicine and imagingArterial input functionChemistrybusiness.industryHeartLaminar flowBlood flowPerfusion reservemedicine.diseaseMagnetic Resonance ImagingStenosismedicine.anatomical_structureCardiologyNuclear medicinebusinessPerfusioncirculatory and respiratory physiologyArteryMagnetic Resonance in Medicine
researchProduct

Selenoprotein synthesis and side-effects of statins.

2004

Statins are possibly the most effective drugs for the prevention and treatment of hypercholesterolaemia and coronary heart disease. They are generally well tolerated, however, they do cause some unusual side-effects with potentially severe consequences, most prominently myopathy or rhabdomyolysis and polyneuropathy. We noted that the pattern of side-effects associated with statins resembles the pathology of selenium deficiency, and postulated that the mechanism lay in a well established, but often overlooked, biochemical pathway--the isopentenylation of selenocysteine-tRNA([Ser]Sec). A negative effect of statins on selenoprotein synthesis does seem to explain many of the enigmatic effects a…

medicine.medical_specialtyHypercholesterolemiaCoronary DiseaseBioinformaticsModels BiologicalRhabdomyolysisPolyneuropathiesSeleniumMuscular DiseasesSelenium deficiencyInternal medicinemedicineHumanscardiovascular diseasesSelenium metabolismMyopathySelenoproteinschemistry.chemical_classificationbusiness.industrynutritional and metabolic diseasesProteinsGeneral Medicinemedicine.diseaseCoronary heart diseaseEndocrinologychemistryProteins metabolismProtein Biosynthesislipids (amino acids peptides and proteins)Selenoproteinmedicine.symptomHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessRhabdomyolysisPolyneuropathyLancet (London, England)
researchProduct

Cardiovascular Events in Rheumatoid Arthritis-Time to See Beyond Articular Involvement in "Real World" Clinical Practice: Comment on the Article by M…

2015

medicine.medical_specialtyImmunologyMEDLINEArthritisCoronary DiseasePeptides CyclicLeft ventricular massArthritis RheumatoidRheumatologyInternal medicinemedicineImmunology and AllergyHumansDiastolic functionStrokeAutoantibodiesbusiness.industryAutoantibodymedicine.diseaseAutoantibodieClinical PracticeStrokeRheumatoid arthritisCardiologyFemalebusinessHumanArthritisrheumatology (Hoboken, N.J.)
researchProduct

Olive oil consumption and risk of CHD and/or stroke: a meta-analysis of case–control, cohort and intervention studies

2014

Increasing evidence suggests that the Mediterranean diet can reduce the risk of CVD. Olive oil is the hallmark of this dietary pattern. We conducted a meta-analysis of case–control, prospective cohort studies and a randomised controlled trial investigating the specific association between olive oil consumption and the risk of CHD (101 460 participants) or stroke (38 673 participants). The results of all observational studies were adjusted for total energy intake. The random-effects model assessing CHD as an outcome showed a relative risk (RR) of 0·73 (95 % CI 0·44, 1·21) in case–control studies and 0·96 (95 % CI 0·78, 1·18) in cohort studies for a 25 g increase in olive oil consumption. In …

medicine.medical_specialtyMediterranean dietMedicine (miscellaneous)Coronary DiseaseDiet MediterraneanCohort StudiesRisk FactorsOleaInternal medicinemedicineHumansPlant Oilscardiovascular diseasesProspective cohort studyOlive OilStrokeRandomized Controlled Trials as TopicEvidence-Based MedicineNutrition and Dieteticsbusiness.industryIncidenceCase-control studyReproducibility of Resultsmedicine.diseaseStrokeCase-Control StudiesFruitRelative riskMeta-analysisCohortPhysical therapybusinessCohort studyBritish Journal of Nutrition
researchProduct

Tissue characterization comparison of culprit lesions between stable coronary disease and ST elevation myocardial infarction patients

2013

medicine.medical_specialtyNecrosisbusiness.industrymedicine.medical_treatmentPercutaneous coronary interventionTissue characterizationCoronary diseasemedicine.diseaseCulpritAtheromaSt elevation myocardial infarctionInternal medicineFactor V LeidenmedicineCardiologyRadiologymedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct

Crataegus laevigata decreases neutrophil elastase and has hypolipidemic effect: a randomized, double-blind, placebo-controlled trial.

2011

Crataegus laevigata is a medicinal plant most commonly used for the treatment of heart failure and psychosomatic disorders. Based on previous experimental findings, this double-blind placebo-controlled study was aimed at finding beneficial effects of C. laevigata on biomarkers of coronary heart disease (CHD). The study included 49 diabetic subjects with chronic CHD who were randomly assigned to the treatment for 6 months with either a micronized flower and leaf preparation of C. laevigata (400 mg three times a day) or a matching placebo. Blood cell count, lipid profile, C-reactive protein, neutrophil elastase (NE) and malondialdehyde were analyzed in plasma at baseline, at one month and six…

medicine.medical_specialtyPlacebo-controlled studyPharmaceutical ScienceCoronary DiseaseFlowersPlaceboGastroenterologyDiabetes Complicationschemistry.chemical_compoundDouble-Blind MethodInterquartile rangeInternal medicineDiabetes mellitusDrug DiscoverymedicineHumansAgedPharmacologyCrataegusmedicine.diagnostic_testbiologybusiness.industryCholesterolPlant ExtractsC-reactive proteinCholesterol LDLMiddle Agedbiology.organism_classificationmedicine.diseaseSurgeryCrataegus laevigataPlant LeavesC-Reactive ProteinComplementary and alternative medicinechemistryDiabetes Mellitus Type 2biology.proteinMolecular MedicineLipid PeroxidationLipid profilebusinessLeukocyte ElastasePhytotherapyPhytomedicine : international journal of phytotherapy and phytopharmacology
researchProduct